Cyber Monday Week - 50% Off. Subscribe Cyber Monday Week
Taiwan News Article Rating

Roche's phase III evERA data showed giredestrant significantly improved progression-free survival in people with ER-positive advanced breast cancer | Taiwan News | Oct. 18, 2025 13:00

  • Bias Rating
  • Reliability

    65% ReliableAverage

  • Policy Leaning

    -50% Medium Left

  • Politician Portrayal

    N/A

Bias Score Analysis

The A.I. bias rating includes policy and politician portrayal leanings based on the author’s tone found in the article using machine learning. Bias scores are on a scale of -100% to 100% with higher negative scores being more liberal and higher positive scores being more conservative, and 0% being neutral.

Sentiments

Overall Sentiment

5% Positive

  •   Liberal
SentenceSentimentBias
Unlock this feature by upgrading to the Pro plan.

Bias Meter

Extremely
Liberal

Very
Liberal

Moderately
Liberal

Somewhat Liberal

Center

Somewhat Conservative

Moderately
Conservative

Very
Conservative

Extremely
Conservative

-100%
Liberal

100%
Conservative

Bias Meter

Contributing sentiments towards policy:

63% : These study results support the potential for the giredestrant combination to become a new standard-of-care for all patients in this setting," said Levi Garraway, MD, PhD, Roche's Chief Medical Officer and Head of Global Product Development.
62% : We are a pioneer in personalised healthcare and want to further transform how healthcare is delivered to have an even greater impact.
59% : 5,18 About Roche in breast cancer Roche has been advancing breast cancer research for more than 30 years, and it continues to be a major focus of research and development.

*Our bias meter rating uses data science including sentiment analysis, machine learning and our proprietary algorithm for determining biases in news articles. Bias scores are on a scale of -100% to 100% with higher negative scores being more liberal and higher positive scores being more conservative, and 0% being neutral. The rating is an independent analysis and is not affiliated nor sponsored by the news source or any other organization.

Copy link